started · updated
Arvand Pharmed prepares for IPO on Tehran Stock Exchange
Arvand Pharmed, a subsidiary of the Sinagen Pharmaceutical Group, is preparing for its initial public offering (IPO) on the Tehran Stock Exchange under the symbol ‘Darvand’. During an introductory meeting held on August 22, 2026, Tamaddon Investment Bank, acting as the underwriter and valuer, announced a final valuation for the company of approximately 7.4 trillion tomans.
Arvand Pharmed specializes in the production of specialized supplements and new chemical drugs. Financial projections for the year 1405 estimate sales of approximately 6 trillion tomans and a net profit exceeding 2 trillion tomans. The company maintains a high gross profit margin, averaging over 65 percent over the last five years.
Sinagen Pharmaceutical Group, the parent company, reported significant economic contributions, including saving over $25 billion in foreign exchange over the past decade. In the year 1404 alone, the group's activities resulted in $6.3 billion in foreign exchange savings. The group currently holds more than 70 percent of Iran's total pharmaceutical export market, with products reaching over 42 countries.
Entities
Arvand Pharmed · Haleh Hamedifar · Sinagen Pharmaceutical Group · Tamaddon Investment Bank · Tehran Stock Exchange
Claims
What the coverage asserts, and how many sources carry each claim.
- [○ 1 SOURCE] The initial estimate for Darvand's sales in 1405 has been increased to approximately 6 trillion tomans. ebtekarnews.com
- [○ 1 SOURCE] The final valuation of Arvand Pharmed (Darvand) is approximately 7.4 trillion tomans. ebtekarnews.com
- [○ 1 SOURCE] The gross profit margin of Zist Arvand Pharmed has averaged higher than 65 percent over the past five years. ebtekarnews.com
- [● 2 SOURCES] Sinagen's activities in the year 1404 resulted in a foreign exchange saving of $6.3 billion. www.daroovasalamat.ir · www.khabarfoori.com
- [● 2 SOURCES] Sinagen Pharmaceutical Group holds more than 70 percent of the country's total pharmaceutical export basket. www.daroovasalamat.ir · www.khabarfoori.com
- [● 2 SOURCES] Sinagen Pharmaceutical Group has saved more than $25 billion in foreign exchange over the last 10 years. www.daroovasalamat.ir · www.khabarfoori.com
- [● 2 SOURCES] Arvand Pharmed is the first company from the Sinagen Pharmaceutical Group to enter the capital market. www.daroovasalamat.ir · www.khabarfoori.com
- [○ 1 SOURCE] The net profit for the company is estimated to be more than 2 trillion tomans for the year 1405. ebtekarnews.com